People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Fintech, Pharmaceuticals, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wefunder, Inc. | — | Fintech | Series A | $24.7M | $9.6M | 2015 |
| LivFul Inc. | — | Pharmaceuticals | Series A | $10.1M | $675K | 2021 |
| Bovie Medical Corp | — | Other Health Care | Series A | $10.0M | $141.3M | 2010 |
| Infinet Development, Inc. | — | Other | Pre-Seed | $328K | $2.1M | 2023 |
MICHAEL NORMAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MICHAEL NORMAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| NICHOLAS TOMMARELLO | 1 | 18 |
| ANDREW BARLOW | 1 | 3 |
| Ryan Hungate | 1 | 2 |
| Brandon Davis | 1 | 2 |
| Greg Belote | 1 | 2 |
| Robert Gershon | 1 | 2 |
| Gary Pickett | 1 | 2 |
| John Manwell | 1 | 1 |
| Yaw Nsarkoh | 1 | 1 |
| Kris Maynard | 1 | 1 |
| Carl Thong | 1 | 1 |
| Wesley Lyons | 1 | 1 |
| Kevin Engel | 1 | 1 |
| Nicholas Tomarello | 1 | 1 |
| August Lentricchia | 1 | 1 |
| Matt Frazier | 1 | 1 |
| Dave Rae | 1 | 1 |
| Ray Rastelli | 1 | 1 |
| Steve Livneh | 1 | 1 |
| Steven Maclaren | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.